Montelukast and Telmisartan as Inhibitors of SARS-CoV-2 Omicron Variant

• मुख्य लेखकों: Nirmitee Mulgaonkar (लेखक), Haoqi Wang (लेखक), Junrui Zhang (लेखक), Christopher M. Roundy (लेखक), Wendy Tang (लेखक), Sankar Prasad Chaki (लेखक), Alex Pauvolid-Corrêa (लेखक), Gabriel L. Hamer (लेखक), Sandun Fernando (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: MDPI AG, 2023-07-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Earlier studies with montelukast (M) and telmisartan (T) have revealed their potential antiviral properties against SARS-CoV-2 wild-type (WT) but have not assessed their efficacy against emerging Variants of Concern (VOCs) such as Omicron. Our research fills this gap by investigating these drugs...